R. C. Huisman

752 total citations
15 papers, 526 citations indexed

About

R. C. Huisman is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, R. C. Huisman has authored 15 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 6 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in R. C. Huisman's work include HIV Research and Treatment (11 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). R. C. Huisman is often cited by papers focused on HIV Research and Treatment (11 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). R. C. Huisman collaborates with scholars based in Netherlands, France and Slovakia. R. C. Huisman's co-authors include Albert D. M. E. Osterhaus, Rob A. Gruters, Carel A. van Baalen, Anna María Geretti, Frank Miedema, Michèl R. Klein, Oscar Pontesilli, F de Wolf, Michael J. Francis and Guus F. Rimmelzwaan and has published in prestigious journals such as PLoS ONE, Journal of Virology and BMJ.

In The Last Decade

R. C. Huisman

15 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. C. Huisman Netherlands	11	395	211	191	170	140	15	526
Francesca Vitone Italy	14	344 0.9×	114 0.5×	95 0.5×	244 1.4×	122 0.9×	29	494
Donna J. Eastman United States	11	291 0.7×	212 1.0×	133 0.7×	106 0.6×	161 1.1×	11	431
Rosemarie D. Mason United States	13	281 0.7×	258 1.2×	145 0.8×	148 0.9×	87 0.6×	38	484
Jennifer Serwanga Uganda	10	176 0.4×	118 0.6×	82 0.4×	219 1.3×	101 0.7×	39	402
Ann-Charlotte Leandersson Sweden	7	329 0.8×	322 1.5×	200 1.0×	233 1.4×	200 1.4×	8	620
Jennifer Kirchherr United States	14	573 1.5×	274 1.3×	117 0.6×	323 1.9×	146 1.0×	28	684
J C Galphin United States	7	188 0.5×	121 0.6×	123 0.6×	124 0.7×	122 0.9×	8	368
Pantxika Bellecave France	12	206 0.5×	76 0.4×	225 1.2×	224 1.3×	154 1.1×	31	575
William A. Lauer United States	9	227 0.6×	162 0.8×	91 0.5×	86 0.5×	86 0.6×	11	352
Kurt Bieler Germany	10	323 0.8×	168 0.8×	114 0.6×	128 0.8×	219 1.6×	11	479

Countries citing papers authored by R. C. Huisman

Since Specialization

Citations

This map shows the geographic impact of R. C. Huisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. C. Huisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. C. Huisman more than expected).

Fields of papers citing papers by R. C. Huisman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. C. Huisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. C. Huisman. The network helps show where R. C. Huisman may publish in the future.

Co-authorship network of co-authors of R. C. Huisman

This figure shows the co-authorship network connecting the top 25 collaborators of R. C. Huisman. A scholar is included among the top collaborators of R. C. Huisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. C. Huisman. R. C. Huisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hoog, Marieke L. A. de, R. C. Huisman, Richard Molenkamp, et al.. (2022). SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation. BMC Infectious Diseases. 22(1). 960–960. 5 indexed citations

Schuit, Ewoud, Irene Veldhuijzen, Roderick P Venekamp, et al.. (2021). Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. BMJ. 374. n1676–n1676. 55 indexed citations

Iglὁi, Zsὁfia, Jans Velzing, R. C. Huisman, et al.. (2021). Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PLoS ONE. 16(12). e0260894–e0260894. 15 indexed citations

Phan, My V. T., Corine H. GeurtsvanKessel, R. C. Huisman, et al.. (2019). Complete Genome Characterization of Eight Human Parainfluenza Viruses from the Netherlands. Microbiology Resource Announcements. 8(15). 3 indexed citations

Huisman, Willem, K H Siebelink, R. C. Huisman, et al.. (1998). Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection. Vaccine. 16(2-3). 181–187. 18 indexed citations

Baalen, Carel A. van, et al.. (1998). Kinetics of Antiviral Activity by Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes (CTL) and Rapid Selection of CTL Escape Virus In Vitro. Journal of Virology. 72(8). 6851–6857. 58 indexed citations

Tijhaar, Edwin, et al.. (1997). Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus.. Journal of General Virology. 78(12). 3265–3275. 2 indexed citations

Baalen, Carel A. van, R. C. Huisman, Michèl R. Klein, et al.. (1997). Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.. Journal of General Virology. 78(8). 1913–1918. 162 indexed citations

Baalen, Carel A. van, Oscar Pontesilli, R. C. Huisman, et al.. (1997). HIV-1 REV and TAT specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to aids. Immunology Letters. 56. 31–31. 14 indexed citations

10.

Baalen, Carel A. van, Michèl R. Klein, R. C. Huisman, et al.. (1996). Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1. Journal of General Virology. 77(8). 1659–1665. 21 indexed citations

11.

Osterhaus, Albert D. M. E., Edwin Tijhaar, R. C. Huisman, et al.. (1996). Accelerated Viremia in Cats Vaccinated with Recombinant Vaccinia Virus Expressing Envelope Glycoprotein of Feline Immunodeficiency Virus. AIDS Research and Human Retroviruses. 12(5). 437–441. 11 indexed citations

12.

Schutten, Martin, J. P. M. Langedijk, Arno C. Andeweg, et al.. (1995). Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains. Journal of General Virology. 76(7). 1665–1673. 8 indexed citations

13.

Siebelink, K H, Edwin Tijhaar, R. C. Huisman, et al.. (1995). Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. Journal of Virology. 69(6). 3704–3711. 100 indexed citations

14.

Rimmelzwaan, Guus F., K H Siebelink, R. C. Huisman, et al.. (1994). Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes. Journal of General Virology. 75(8). 2097–2102. 22 indexed citations

15.

Schutten, Martin, Áine McKnight, R. C. Huisman, et al.. (1993). Further characterization of an antigenic site of HIV-I gp120 recognized by virus neutralizing human monoclonal anti bodies. AIDS. 7(7). 919–924. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact